Zoryve is under clinical development by Arcutis Biotherapeutics and currently in Pre-Registration for Psoriasis.

A new study uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first to activate specific components of the ...

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, ...

The global topical wound agents market is poised for significant growth, with projected revenue rising from US$ 1,856.6 ...

Krystal Biotech's VYJUVEK, a groundbreaking gene therapy for DEB, achieved $83.8M in Q3 2024 sales. Read why I rate KRYS ...

Biotin is a popular ingredient for hair growth, but it may not be the most effective. We spoke with experts about whether ...

The product was never submitted for approval by the FDA and is an unapproved drug for which safety and efficacy have not been ...

To learn more about the drug, see this in-depth hydroxyzine oral tablet article. And for more information about other forms of hydroxyzine, talk with your doctor or pharmacist. The following table ...

Ondansetron is a generic drug that’s prescribed for prevention ... see this step-by-step guide for tips on how to take this form of medication. You can also talk with your doctor or pharmacist.

The company was seeking approval for the subcutaneous version of the drug to treat patients with non-small cell lung cancer (NSCLC) who have mutated form of a gene called epidermal growth factor ...